ml 23 has been researched along with levodopa in 2 studies
| Studies (ml 23) | Trials (ml 23) | Recent Studies (post-2010) (ml 23) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 13 | 1 | 0 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | ml 23 (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Willis, GL | 2 |
1 review(s) available for ml 23 and levodopa
| Article | Year |
|---|---|
The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson's disease.
Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Disease Models, Animal; Humans; Levodopa; Melatonin; Parkinson Disease | 2005 |
1 other study(ies) available for ml 23 and levodopa
| Article | Year |
|---|---|
Intraocular microinjections repair experimental Parkinson's disease.
Topics: 5-Methoxytryptamine; Animals; Antiparkinson Agents; Circadian Rhythm; Levodopa; Male; Microinjections; Motor Activity; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Retina | 2008 |